Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspectiveStress, dysregulation of drug reward pathways, and the transition to drug dependenceThe effects of herkinorin, the first mu-selective ligand from a salvinorin A-derived scaffold, in a neuroendocrine biomarker assay in nonhuman primatesReactivity to laboratory stress provocation predicts relapse to cocaineSalvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disordersκ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addictionIndividual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in ratsNalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humansAssociation of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsSteady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.Heroin-induced locomotor activity and conditioned place preference in C57BL/6J and 129P3/J micePET imaging of leptin biodistribution and metabolism in rodents and primates.Dose preference and dose escalation in extended-access cocaine self-administration in Fischer and Lewis rats.Dose escalation and dose preference in extended-access heroin self-administration in Lewis and Fischer ratsThe BiolAD-DB system : an informatics system for clinical and genetic data.Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry.Primary structure of guinea pig preprodynorphin and preproenkephalin mRNAs: multiple transcription initiation sites for preprodynorphin.Microarray studies of psychostimulant-induced changes in gene expression.Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.Determination of Salvinorin A in body fluids by high performance liquid chromatography-atmospheric pressure chemical ionization.Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.Drug addiction and stress-response genetic variability: association study in African Americans.The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.Community-dwelling cocaine-dependent men and women respond differently to social stressors versus cocaine cuesPharmacotherapy in the treatment of addiction: methadone.Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors.Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.Identification of substance use and dependence among patients with viral hepatitis.Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.Effects of hepatitis C and HIV on cognition in women: data from the Women's Interagency HIV Study.Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction.Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver disease.TPH2 and TPH1: association of variants and interactions with heroin addiction.Haplotype block structure of the genomic region of the mu opioid receptor gene.
P50
Q24603044-EF28BE1E-A0BA-40A3-B25E-4AB987F896DEQ24629577-42014BFC-8407-437D-8A2D-4828705C793AQ24652924-67B7D3AF-62AE-4980-B3E6-B58E8F067D89Q24655024-434CE513-AFFD-423F-A580-0CF5B3FFA9A0Q26781580-4F82FB13-714A-4D93-8FC8-9C03D330EF88Q26864309-32C5A67A-B290-49AD-8079-0B74C1447416Q27304542-231D4D49-8D9C-4888-940D-D5B0A00DE169Q28259148-177F2DF6-E9C4-41F9-982A-6DF61CE967F1Q28270135-73B1BC37-CA5F-4EF4-A3D4-A6A5E76FE7B4Q30316113-9A581436-7579-42FF-A433-7A5187EE8863Q30480561-454548D8-2B73-4CC4-B90A-ACE2348B02DEQ30487574-9B6DF4EF-EF86-4F6F-BB98-BF1B3A9CBDE5Q30494418-B33CFE58-7866-4A32-B8C2-A5552B08286BQ30496229-494C2D53-7127-4EDD-B989-87B0E9177E6CQ30514193-8E55F647-C343-4CA5-A3FC-FCF0AA45DBD4Q31098964-A7C72986-3752-4F9E-8FF0-27B740F31FD1Q31151085-E3F1E926-3032-4E47-8B65-6A96A19E02A3Q33202701-9AECDFAE-FC93-4CD1-AC97-3792C6039638Q33214334-6F75F6FE-831D-4D4B-8DEA-F804DEDF992CQ33313052-D10EE482-A05F-41C3-A5D4-7BB264EB005FQ33432985-734BF864-CDA0-4725-9A48-EC90725DFAA7Q33600448-DB8D0CAE-202E-4A8B-AF80-F0B5EC3918A5Q33643136-9E9B64AE-6301-4A4D-BB3C-B870777746A0Q33784764-6480861B-7C01-4039-ADDE-B4661BF00510Q33835281-078A72DF-B9E2-4ECD-A7D5-185659BAB0C7Q33835424-37C48FD6-E8BC-487E-9475-D6727F02CA18Q33872495-2B753C78-1EE1-4D6D-931D-8169EF7ECD6FQ33914167-82AEF5CD-C06C-4830-85A5-7E4D8B57F937Q33984723-807A702A-75C2-46E3-9494-0FFEBA1430FFQ34016279-61AF7BA2-0FD5-41FC-AAB3-CB3C2CABBD61Q34023364-7CC062E5-2B4C-4013-8A3B-FA34F7DDB7B2Q34033200-28A4CD93-ECA7-406F-AB06-9E5AEE38E746Q34080255-112DB8D7-8AE7-44C3-ADD8-AEC2A042A477Q34118780-70B7E4ED-5698-4FFC-8E7C-3A05FB7A8746Q34463235-0DC5B187-0450-4209-82B2-D17F5686D745Q34553042-4EEB606C-7624-4A17-A816-FFA1ACCC7950Q34656790-799FA1F1-B7DC-47FC-B6EB-C3702C3031FDQ34671102-BBEBC5CC-02B9-47F6-9F76-F610CC1E4102Q34734000-B8B523D2-D304-4FA4-97F8-B31B876A74AFQ34786964-677694E7-F2EF-42F5-B758-3D72B736CBAF
P50
description
American neurobiologist
@en
name
Mary Jeanne Kreek
@ast
Mary Jeanne Kreek
@cy
Mary Jeanne Kreek
@en
Mary Jeanne Kreek
@es
Mary Jeanne Kreek
@fr
Mary Jeanne Kreek
@nl
Mary Jeanne Kreek
@sl
type
label
Mary Jeanne Kreek
@ast
Mary Jeanne Kreek
@cy
Mary Jeanne Kreek
@en
Mary Jeanne Kreek
@es
Mary Jeanne Kreek
@fr
Mary Jeanne Kreek
@nl
Mary Jeanne Kreek
@sl
prefLabel
Mary Jeanne Kreek
@ast
Mary Jeanne Kreek
@cy
Mary Jeanne Kreek
@en
Mary Jeanne Kreek
@es
Mary Jeanne Kreek
@fr
Mary Jeanne Kreek
@nl
Mary Jeanne Kreek
@sl
P214
P244
P21
P213
0000 0000 2152 1826
P214
P2381
P244
P31
P569
1937-01-01T00:00:00Z
P735
P7859
lccn-n78013347